ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.8834
1.02%
Brent Oil
77.515
-0.80%
Bitcoin
70,210.01
2.04%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
04/06/202415:05GlobeNewswire Inc.Nasdaq May 2024 VolumesNASDAQ:NDAQNasdaq Inc
04/06/202415:05Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:INFNInfinera Corporation
04/06/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
04/06/202415:05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
04/06/202415:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:PFLTPennantPark Floating Rate Capital Ltd
04/06/202415:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EVGOWEVgo Inc
04/06/202415:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INTSIntesity Therapeutics Inc
04/06/202415:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MFINMedallion Financial Corporation
04/06/202415:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CPOPPop Culture Group Company Ltd
04/06/202415:05Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNASDAQ:SPTNSpartanNash Company
04/06/202415:05GlobeNewswire Inc.Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja California Desalination ProjectNASDAQ:CWCOConsolidated Water Company Ltd
04/06/202415:04Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:APTV-AAptiv PLC
04/06/202415:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SPTSprout Social Inc
04/06/202415:03Business WireKORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology BiologicNASDAQ:KRMDKORU Medical Systems Inc
04/06/202415:02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:INTSIntesity Therapeutics Inc
04/06/202415:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:MYOMyomo Inc
04/06/202415:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XOSWWXos Inc
04/06/202415:01PR Newswire (Canada)goeasy Ltd. to Present at TD Cowen Financial Services & Fintech SummitTSX:GSYGoeasy Ltd
04/06/202415:01Business WireNetApp Hosts Investor DayNASDAQ:NTAPNetApp Inc
04/06/202415:01GlobeNewswire Inc.S Split Corp. Declares Monthly DistributionSBN-PR
04/06/202415:01GlobeNewswire Inc.Celldex Therapeutics to Present at Jefferies Healthcare ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
04/06/202415:01GlobeNewswire Inc.Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF ClassTSX:MPYMulvihill Premium Yield Fund
04/06/202415:01GlobeNewswire Inc.Top 10 Split Trust Declares Quarterly Fund DistributionsTXT-PA
04/06/202415:01GlobeNewswire Inc.Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:ASNDAscendis Pharma AS
04/06/202415:01GlobeNewswire Inc.PrairieSky Royalty Declares Quarterly DividendTSX:PSKPrairieSky Royalty Ltd
04/06/202415:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/06/202415:01GlobeNewswire Inc.Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly DistributionTSX:XLVEMulvihill US Health Care Enhanced Yield ETF
04/06/202415:01GlobeNewswire Inc.World Financial Split Corp. Declares Quarterly Preferred Share DistributionTSX:WFSWorld Financial Split Corp
04/06/202415:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
04/06/202415:01GlobeNewswire Inc.Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FATEFate Therapeutics Inc

Su Consulta Reciente

COIN
LDOGEEUR
NYSE
WSM
Williams Sonoma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados